Cargando…

Flagellin/Virus-like Particle Hybrid Platform with High Immunogenicity, Safety, and Versatility for Vaccine Development

[Image: see text] Hepatitis B core (HBc) virus-like particles (VLPs) and flagellin are highly immunogenic and widely explored vaccine delivery platforms. Yet, HBc VLPs mainly allow the insertion of relatively short antigenic epitopes into the immunodominant c/e1 loop without affecting VLP assembly,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Yiwen, Li, Zhuofan, Voyer, Jewel, Li, Yibo, Chen, Xinyuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2022
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121874/ https://www.ncbi.nlm.nih.gov/pubmed/35467839 http://dx.doi.org/10.1021/acsami.2c01028

Ejemplares similares

Vaccine delivery alerts innate immune systems for more immunogenic vaccination
por: Li, Zhuofan, et al.
Publicado: (2021)

Adjuvantation of Influenza Vaccines to Induce Cross-Protective Immunity
por: Li, Zhuofan, et al.
Publicado: (2021)

The truncated form of flagellin (tFlic) provides the 2dCap subunit vaccine with better immunogenicity and protective effects in mice
por: Lu, Ying, et al.
Publicado: (2022)

Virus-Like Particles, a Versatile Subunit Vaccine Platform
por: Donaldson, Braeden, et al.
Publicado: (2014)

Virus-Like Particles as an Immunogenic Platform for Cancer Vaccines
por: Caldeira, Jerri C., et al.
Publicado: (2020)

Comparative tissue proteomics reveals unique action mechanisms of vaccine adjuvants
por: Li, Yibo, et al.
Publicado: (2022)

Potentiation of Recombinant NP and M1-Induced Cellular Immune Responses and Protection by Physical Radiofrequency Adjuvant
por: Li, Yibo, et al.
Publicado: (2021)

Hybrid flagellin as a T cell independent vaccine scaffold
por: Bennett, Kaila M., et al.
Publicado: (2015)

Effective adjuvantation of nanograms of influenza vaccine and induction of cross-protective immunity by physical radiofrequency adjuvant
por: Li, Zhuofan, et al.
Publicado: (2022)

Phase 1 Safety and Immunogenicity Study of a Quadrivalent Seasonal Flu Vaccine Comprising Recombinant Hemagglutinin-Flagellin Fusion Proteins
por: Tussey, Lynda, et al.
Publicado: (2016)

NLRC4 Inflammasome-Driven Immunogenicity of a Recombinant MVA Mucosal Vaccine Encoding Flagellin
por: Sanos, Stephanie L., et al.
Publicado: (2018)

Flashy flagella: flagellin modification is relatively common and highly versatile among the Enterobacteriaceae
por: De Maayer, Pieter, et al.
Publicado: (2016)

Incorporation of membrane-anchored flagellin or Escherichia coli heat-labile enterotoxin B subunit enhances the immunogenicity of rabies virus-like particles in mice and dogs
por: Qi, Yinglin, et al.
Publicado: (2015)

Versatile Virus-Like Particle Carrier for Epitope Based Vaccines
por: Tissot, Alain C., et al.
Publicado: (2010)

Commentary: Incorporation of membrane-anchored flagellin or Escherichia coli heat-labile enterotoxin B subunit enhances the immunogenicity of rabies virus-like particles in mice and dogs
por: Kumar, Arun
Publicado: (2015)

Immunogenicity and Efficacy of Flagellin-Fused Vaccine Candidates Targeting 2009 Pandemic H1N1 Influenza in Mice
por: Liu, Ge, et al.
Publicado: (2011)

Recent Progress on the Versatility of Virus-Like Particles
por: Qian, Ciying, et al.
Publicado: (2020)

Virus-like Particle Vaccines and Platforms for Vaccine Development
por: Kheirvari, Milad, et al.
Publicado: (2023)

Immunogenicity and safety of virus-like particle of the porcine encephalomyocarditis virus in pig
por: Jeoung, Hye-Young, et al.
Publicado: (2011)

Flagellin as Carrier and Adjuvant in Cocaine Vaccine Development
por: Lockner, Jonathan W., et al.
Publicado: (2014)

104 Immunogenicity and Safety Aspects of Adeno-Associated Virus–Like Particles (AAVLPS) as Carriers for B-Cell Vaccines
por: Jensen-Jarolim, Erika, et al.
Publicado: (2012)

Overcoming Aging-Associated Poor Influenza Vaccine Responses with CpG 1018 Adjuvant
por: Kang, Xinliang, et al.
Publicado: (2022)

Modular vaccine platform based on the norovirus-like particle
por: Lampinen, Vili, et al.
Publicado: (2021)

Virus-Like Particles Containing the Tetrameric Ectodomain of Influenza Matrix Protein 2 and Flagellin Induce Heterosubtypic Protection in Mice
por: Wang, Li, et al.
Publicado: (2013)

A Versatile PDMS/Paper Hybrid Microfluidic Platform for Sensitive Infectious Disease Diagnosis
por: Dou, Maowei, et al.
Publicado: (2014)

Deimmunization of flagellin for repeated administration as a vaccine adjuvant
por: Khim, Koemchhoy, et al.
Publicado: (2021)

Inclusion of cGAMP within virus‐like particle vaccines enhances their immunogenicity
por: Chauveau, Lise, et al.
Publicado: (2021)

Immunogenicity and protective efficacy against Treponema pallidum in New Zealand rabbits immunized with plasmid DNA encoding flagellin
por: Zheng, Kang, et al.
Publicado: (2018)

N-terminus of flagellin enhances vaccine efficacy against Actinobacillus pleuropneumoniae
por: Chuekwon, Kamonpun, et al.
Publicado: (2022)

Virus like particles as a platform for cancer vaccine development
por: Ong, Hui Kian, et al.
Publicado: (2017)

Safety and immunogenicity of plant-produced African horse sickness virus-like particles in horses
por: Dennis, Susan J., et al.
Publicado: (2018)

Immunogenicity and protective efficacy of Vibrio vulnificus flagellin protein FlaB in a wound infection model
por: YAMAZAKI, Kohei, et al.
Publicado: (2017)

Safety and immunogenicity of a heterologous booster with an RBD virus-like particle vaccine following two- or three-dose inactivated COVID-19 vaccine
por: Yong, Xiaolan, et al.
Publicado: (2023)

DNA Vaccine-Encoded Flagellin Can Be Used as an Adjuvant Scaffold to Augment HIV-1 gp41 Membrane Proximal External Region Immunogenicity
por: Ajamian, Lara, et al.
Publicado: (2018)

Studies on the Use of Flagellin as an Immunostimulant and Vaccine Adjuvant in Fish Aquaculture
por: Wangkahart, Eakapol, et al.
Publicado: (2019)

Enhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine
por: Collins, Katharine A., et al.
Publicado: (2017)

Immunogenicity and protective potency of Norovirus GII.17 virus-like particle-based vaccine
por: Chen, Wei, et al.
Publicado: (2020)

Design and immunogenicity assessment of HIV-1 virus-like particles as a candidate vaccine
por: Zhang, XiZhen, et al.
Publicado: (2011)

Flagellin shifts 3D bronchospheres towards mucus hyperproduction
por: Sprott, Richard F., et al.
Publicado: (2020)

Distinctive Recognition of Flagellin by Human and Mouse Toll-Like Receptor 5
por: Forstnerič, Vida, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_pc5nru49c4sgdbq5fddh9qhrht